Medicare Part D coverage · fosinopril sodium · RxCUI 857187
fosinopril sodium 40 MG Oral Tablet
Per the CMS 2026 Part D formulary file, fosinopril sodium 40 MG Oral Tablet is covered by 4,936 Medicare Part D plans (97.7% of enrollable products), averaging Tier 2.3, with prior authorization required on 0% of covering formularies.
- 97.7%
- Plan coverage
- 4,936
- Plans covering
- T2.3
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for fosinopril sodium 40 MG Oral Tablet
Per the CMS 2026 Part D formulary file, fosinopril sodium 40 MG Oral Tablet (RxNorm concept RXCUI 857187, generic name fosinopril sodium) appears on 325 distinct formulary files spanning 4,936 Medicare Part D plan offerings - 97.7% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.3.
Real-world access to fosinopril sodium 40 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0.9% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 50,736 Part D beneficiaries filled fosinopril sodium 40 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $5,895,713 and an average per-beneficiary annual cost of $116.20. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry fosinopril sodium 40 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 325
- Plans covering
- 4,936
- Coverage rate
- 97.7%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0.9% of formularies
2023 Medicare Spending
- Beneficiaries
- 50,736
- Total spending
- $5,895,713
- Avg per beneficiary
- $116.20
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering fosinopril sodium 40 MG Oral Tablet
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T1 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T1 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering fosinopril sodium 40 MG Oral Tablet
98 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| UHC Dual Complete IA-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | IA |
| UHC Dual Complete MO-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | MO |
| UHC Dual Complete NE-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | NE |
| UHC Dual Complete KS-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | KS |
| UHC Dual Complete MO-S3 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | MO |
| UHC Dual Complete KS-Q1 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | KS |
| UHC Dual Complete TN-S001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| UHC Dual Complete TN-Y001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| UHC Dual Complete TN-Y2 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| AARP Medicare Advantage from UHC MI-0001 (PPO) | Unitedhealthcare Insurance Company | T1 | No | $0 | MI |
| UHC Dual Complete NM-Y1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete NM-S1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete NM-V1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete AZ-S001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T1 | No | $0 | AZ |
| UHC Dual Complete AZ-Y001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T1 | No | $0 | AZ |
| UHC Dual Complete VA-Y4 (PPO D-SNP) | Care Improvement Plus South Central Insurance Co. | T1 | No | $0 | VA |
| AARP Medicare Advantage from UHC AL-0001 (HMO-POS) | Unitedhealthcare OF THE Midlands, Inc. | T1 | No | $0 | AL |
| AARP Medicare Advantage from UHC CA-0002 (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
| UHC Sharp Medicare Advantage CA-001P (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
| AARP Medicare Advantage from UHC CA-003P (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
Show the next 30 plans
Showing top 50 of 98 plans.
Frequently Asked Questions
Is fosinopril sodium 40 MG Oral Tablet covered by Medicare Part D?
Yes, fosinopril sodium 40 MG Oral Tablet is covered by 4,936 Medicare Part D plans (97.7% of all Part D formularies).
What tier is fosinopril sodium 40 MG Oral Tablet on Medicare Part D plans?
fosinopril sodium 40 MG Oral Tablet averages Tier 2.3 across Part D plans, ranging from Tier 1 to Tier 6.
Does fosinopril sodium 40 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for fosinopril sodium 40 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0.9%.
How much does Medicare spend on fosinopril sodium 40 MG Oral Tablet?
In 2023, total Medicare Part D spending on fosinopril sodium 40 MG Oral Tablet was $5,895,713, covering 50,736 beneficiaries. The average spend per beneficiary was $116.20.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 0.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe [Ticovac] T2.3
- 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [PEDIARIX] T2.3
- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet T2.3
- sodium polystyrene sulfonate 15000 MG Powder for Oral Suspension T2.3
- oxycodone hydrochloride 30 MG Oral Tablet T2.3
- amlodipine 10 MG / valsartan 160 MG Oral Tablet T2.3
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA